Evaluation of PACE4 isoforms as biomarkers in thyroid cancer

Abstract Background To date, no single molecular marker has been demonstrated as clinically useful in differentiating malignant from benign thyroid nodules when a fine needle aspiration falls in the “unknown significance” categories of the Bethesda Classification. PACE4, a member of the proprotein c...

Full description

Bibliographic Details
Main Authors: Laurent Fradet, Rabia Temmar, Frédéric Couture, Mathieu Belzile, Pierre-Hugues Fortier, Robert Day
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40463-018-0311-x